MILIND JAVLE to Oncogene Proteins, Fusion
This is a "connection" page, showing publications MILIND JAVLE has written about Oncogene Proteins, Fusion.
Connection Strength
0.215
-
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
Score: 0.128
-
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS One. 2014; 9(12):e115383.
Score: 0.087